Early detection rate changes from a brain‐responsive neurostimulation system predict efficacy of newly added antiseizure drugs

OBJECTIVE: Brain‐responsive neurostimulation (RNS System, NeuroPace) is used to treat medically refractory focal epilepsy and also provides long‐term ambulatory neurophysiologic data. We sought to determine whether these data could predict the clinical response to antiseizure drugs (ASDs). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Quraishi, Imran H., Mercier, Michael R., Skarpaas, Tara L., Hirsch, Lawrence J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Full‐length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003822/
https://www.ncbi.nlm.nih.gov/pubmed/31849045
http://dx.doi.org/10.1111/epi.16412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003822/
https://www.ncbi.nlm.nih.gov/pubmed/31849045
http://dx.doi.org/10.1111/epi.16412

Ejemplares similares